Company: LIMN
Filing Date: 2025-05-06
Form Type: 8-K
Source: 0001104659-25-045127
Chunk: 4

Company: Liminatus Pharma, Inc.
Filing Date: 2025-05-06
Form: 8-K
Item: Item 5.01
Chunk 4
---
Item 5.01. Changes in Control of Registrant.

The information set forth
above under “ Introductory Note” and Item 2.01 of this Report is incorporated herein by reference. Reference is also made to
the disclosure in the Proxy Statement/Prospectus in the section titled “ The Business Combination Proposal” beginning
on page 103, which is incorporated herein by reference. Further reference is made to the information contained in Item 2.01 to this
Report, which is incorporated herein by reference.

Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Directors and Executive Officers